Sinovac Files Clinical Trial Application with SFDA for Vaccine Against Hand, Foot, and Mouth Disease (PR Newswire)
German Merck sees chemical, pharma acquisitions (Reuters)
Sunesis Pharmaceuticals Regains NASDAQ Compliance (MarketWire)
Emerald BioStructures Publication in Nature Biotechnology Details Discovery of Allosteric Small Molecule Modulators of PDE4 with Reduced Side Effects (BusinessWire)
Soligenix Announces Publication of Positive Pre-Clinical Results with RiVax(TM), Its Vaccine Against Ricin Toxin (PR Newswire)
Cell Therapeutics, Inc. Adopts Shareholder Rights Plan (PR Newswire)
Bristol-Myers Squibb Closes Mead Johnson Split-Off (Financial Wire.net)
FDA Reviewing Questcor’s Supplemental New Drug Application (Financial Wire.net)
ABC2 grants funds to Agios Pharma for investigation of IDH1 gene mutations in brain cancer (PharmaBiz)
Stanford scientists identify protein that keeps stem cells poised for action (Genetic Engineering News)
Teva-KOWA to acquire a majority share in Taisho (BioSpectrum)
Health care a little more upbeat than other sectors (Denver Business Journal)
GSK reveals physician payments (American Medical News)